Search for: "NOVO NORDISK PHARMACEUTICALS, INC."
Results 1 - 20
of 88
Sorted by Relevance
|
Sort by Date
15 Sep 2017, 4:33 am
Department of Justice (DOJ) announced pharmaceutical manufacturer Novo Nordisk Inc. has agreed to pay $58.65 million for failing to comply with a Food and Drug Administration (FDA) mandated Risk Evaluation and Mitigation Strategy (REMS) program. [read post]
27 Jul 2011, 4:06 pm
The panel invited a response from Plaintiffs-Appellants Novo Nordisk A/S and Novo Nordisk, Inc. [read post]
11 Sep 2017, 12:30 pm
Pharmaceutical Manufacturer Novo Nordisk Inc. [read post]
20 Jun 2013, 9:59 pm
Correspondingly, in its third Novo Nordisk A/S v. [read post]
30 Mar 2012, 6:59 am
A class of sales representative this month filed a $70 million suit against Novartis Pharmaceuticals Corp., a subsidiary of Danish pharmaceutical giant Novo Nordisk, Inc., in the U.S. [read post]
5 Apr 2012, 8:27 pm
District Court for the Southern District of New York against Novo Nordisk, Inc., a Danish pharmaceuticals company. [read post]
7 Mar 2012, 11:40 am
Pharmaceutical giant Novo Nordisk, Inc. [read post]
15 Sep 2008, 10:48 pm
Novo Nordisk Pharmaceutical Industries, Inc. v. [read post]
16 Jul 2012, 10:17 am
Novo Nordisk A/S 566 U.S. ___, 132 S. [read post]
30 Nov 2011, 8:26 am
Novo Nordisk. [read post]
10 Jun 2011, 7:11 am
According to DOJ’s press release: Novo Nordisk Inc., a Danish pharmaceutical manufacturer, has agreed to pay $25 million to resolve its civil liability arising from the illegal promotion of its hemostasis management drug, NovoSeven, the Justice Department announced today. [read post]
15 Apr 2010, 11:19 am
Novo Nordisk v. [read post]
6 May 2024, 8:26 am
The Federal Trade Commission (FTC) announced late last month that it had “expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book, disputing junk patent listings for diabetes, weight loss, asthma, and COPD drugs, including Novo Nordisk Inc. [read post]
28 Aug 2014, 5:09 pm
New Alzheimer's Drug Shows Promise It was of interest to note that commercials on CBS following the story included for Levemor (Novo Nordisk) and for Brisdelle (Noven, low dose paroxetine). [read post]
9 Dec 2011, 1:00 pm
Novo Nordisk A/S Martel v. [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
27 Jul 2020, 4:51 pm
Novo Nordisk, the First Circuit affirmed a district court judgment that prevented pharmaceutical company Novo Nordisk Inc. from enforcing a confidentiality and non-compete agreement that it had entered into with employee Thomas Russomano, who was briefly laid off and rehired before leaving the company for a competing company. [read post]
14 Apr 2017, 1:10 pm
Novo Nordisk, Inc., 2011 WL 1085015 (S.C. [read post]
19 Apr 2012, 9:00 am
This case originated with Novo Nordisk AS bringing an action against Caraco Pharmaceutical Laboratories Inc. for infringement of Novo’s patent for repaglinide. [read post]
11 Jun 2020, 8:46 am
In January 2020, Russomano resigned from Novo Nordisk and accepted employment with a competitor, BioMarin Pharmaceutical, Inc. [read post]
